Adult-type hypolactasia results from the progressive decline of lactase-phlorizin hydrolase activity in enterocytes after weaning. Lactase nonpersistence may determine a primary lactose intolerance with reduced diary product consumption, which is possibly related to an increased risk of colon cancer. Recently, a genetic variant C/T -13910 upstream of the lactase-phlorizin hydrolase (LCT) gene has been strongly correlated with the lactase persistence/nonpersistence trait in both family and case-control studies. The authors validate a denaturing high-performance liquid chromatography (dHPLC)-based assay versus conventional genotype sequencing in detecting the C/T -13910 polymorphism of LCT and evaluate its prevalence in 2 different Italian geographical areas and in colorectal cancer patients. DNA samples of 157 healthy subjects and 124 colon cancer patients from Apulia and of 97 healthy subjects from Sardinia were evaluated for the C/T -13910 polymorphism by dHPLC, sequencing, and restriction fragment length polymorphism (RFLP). Under optimized conditions, dHPLC was as sensitive as DNA sequencing and detected a new genetic variant (T/C -13913 ) in 2 individuals that was not identified by RFLP assay. Frequency of lactase nonpersistence genotype (C/C -13910 ) was similar in healthy subjects from 2 different Italian geographical areas and not increased in patients with colorectal cancer. The results indicate that the dHPLC method may be used as a rapid, noninvasive, and laborsaving screening tool for genotyping C/T -13910 polymorphism, with high success, low cost, and reproducibility. (Journal of Biomolecular Screening 2007:733-739) 
INTRODUCTION
L ACTASE PERSISTENCE varies widely in frequency among different human populations, both between and within continents. It is most prevalent in Northwestern Europe, with the highest frequency in Sweden and Denmark, and it shows a decline in frequency in Southern Europe. 1 Based on family studies, lactase nonpersistence is inherited as an autosomal recessive trait, and a single-nucleotide polymorphism (rs4988235), upstream of the lactase gene (LCT [MIM: 603202]) at position -13910 carrying a change C-> T, was reported to perfectly match with phenotypic hypolactasia and lactose malabsorption for the C/C genotype. 2 The significant association of the C/T -13910 variant with lactase activity in the intestinal wall has facilitated large-scale population studies of the effect of lactase activity on the development of different diseases by genotyping the DNA variant. Several studies have evaluated the association of the lactase genotype in the development of osteoporosis, type 1 and 2 diabetes, and colon cancer with discordant results. 3 Our study evaluates a fast and sensitive screening test for the LCT-C/T -13910 polymorphism by denaturing high-performance liquid chromatography (dHPLC; Transgenomic Inc., San Jose, CA). This method is based on heteroduplex detection in PCR samples with internal sequence variation. 4 Because of weaker interaction with the column matrix, partially denatured heteroduplex DNA is eluted earlier than the intact double-stranded counterparts, giving rise to double or multiple peaks in the chromatogram. Single peaks represent homozygote genotypes. The method has proven to be a sensitive and economical technique for screening genetic alterations in various genes with detection rates of 92% to 100%. [5] [6] [7] [8] [9] After condition optimization, the dHPLC-based assay was used to perform genotyping of the LCT-C/T -13910 on DNA samples from healthy individuals and colorectal cancer (CRC) patients. Healthy subjects were randomly selected from 2 distinct Italian geographical areas: Apulia and Sardinia. Apulia is a Southern Italian region that shares the common genetic background of Mediterranean populations with a relatively high level of within-population heterogeneity. Conversely, Sardinia is an island with a relatively isolated ethnic group that is genetically more homogeneous than most Western populations. All CRC patients were recruited in Apulia.
MATERIALS AND METHODS

Study population
Blood samples of 2 different healthy populations were randomly collected: 157 were unrelated subjects (155 males, mean age, 38 ± 11 years; range, 19-47 years) born and resident in Apulia and 97 (39 males; mean age, 22 ± 18 years; range, 1-73 years) born and resident in Sardinia ( Table 1) . We also enrolled 124 CRC patients (69 men; mean age, 66 ± 13 years; range, 44-88 years) diagnosed at CSS Hospital in San Giovanni Rotondo (Apulia) during the past 3 years. Demographic data, tumor location, American Joint Committee on Cancer (AJCC) staging, and histological grading of CRC patients are shown in Table 1 . Genomic DNA from healthy controls and patients were obtained from peripheral blood samples, and DNA was isolated using standard techniques. Written informed consent was obtained from all the subjects. The study was approved by ethics committees at each center.
Genotyping
The C/T -13910 polymorphic site was genotyped by PCR followed by dHPLC, automated sequencing, and restriction fragment length polymorphism (RFLP).
For dHPLC and sequencing, the oligonucleotides 5′-GAGTG-TAGTTGTTAGACGGAGAC-3′ and 5′-AGACGACCTTACAT-CAAACCT-3′ were used as primers, and DNA was amplified using AmpliTaq Gold ® DNA polymerase (Applied Biosystems, Applera, Foster City, CA). Amplification cycles consisted of an initial denaturation at 95 °C for 5 min, followed by 40 cycles run at 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 1 min and a final extension step of 72 °C for 6 min.
For automated sequencing, PCR was repeated, and the forward and reverse DNA sequences of amplified product were determined by using an ABI 310 DNA Sequencer (Applied Biosystems).
For the RFLP assay, the single-nucleotide polymorphism (SNP) was typed using the method described by Büning and others. 10 Digestion of the PCR product (448 bp), with the restriction enzyme BsmFI, revealed fragments of 351 bp and 97 bp in the case of the C-allele and of 253 bp, 98 bp, and 97 bp in the case of the T-allele that were resolved on a 2% agarose gel, which was scored under an ultraviolet illuminator after staining with ethidium bromide. 10
DHPLC analysis of heterozygous and homozygous sequence variants
Heteroduplexes were formed when the crude PCR products were denatured at 95 °C for 5 min, followed by gradual cooling from 95 °C to 25 °C over a period of 1 h. Seven microliters of each PCR product was then analyzed using the Wave ® System 2100 A (Transgenomic Inc.). DNA was eluted with a mixture of buffer A (0.1 mol/L triethylammonium acetate [TEEA] solution) and buffer B (0.1 mol/L TEEA containing 25% acetonitrile) at a flow rate of 0.9 mL/min. Melting profiles for each DNA fragment were generated by Navigator 1.5.2 software (Transgenomic Inc.), based on the sequence contents. The temperature and the buffer B gradient to identify the C/T -13910 polymorphism were 58.4 °C and 55.6%, respectively. The analysis of homozygous sequence variants was essentially the same as for heterozygous variants. DNA fragments of wildtype control and samples were analyzed in 2 separate analyses. Subsequently, control and samples were mixed in equal concentration and reanalyzed. A fragment was considered abnormal when the shape or width of the peak was different from that of the wild-type control. The average analysis time per sample took 8 to 12 min, including a regeneration and equilibration step. The linear acetonitrile gradient was adjusted to a retention time of the DNA peak at 4 to 5 min.
Study design
All 378 subjects in the study were analyzed by dHPLC. A total of 150 samples (130 from Apulia population and 20 from Sardinia population) were also analyzed by direct sequencing, and all 97 subjects from Sardinia populations were analyzed by RFLP assay, too. Results from dHPLC, direct sequencing, and RFLP were analyzed independently by 3 investigators.
Statistical analysis
The Hardy-Weinberg equilibrium was tested by using Arlequin software (version 2.000). 11 The genotype distribution was evaluated using the χ 2 method (significance set at p < 0.05), calculated by SPSS statistical package version 13 (SPSS Inc., Chicago, IL).
RESULTS AND DISCUSSION
Optimal conditions of the dHPLC-based analysis of the C/T -13910 polymorphism and comparison of results obtained by dHPLC, sequencing, and RFLP methods
The dHPLC assay conditions for the polymorphic site at -13910 of the LCT gene were established separately by reference to its specific melting curve determined by Navigator software (Fig. 1A, B) . At exact temperature conditions (58.4 °C) and buffer B gradient (55.6%), the identification of samples with internal sequence variations was a straightforward procedure. Elution profiles of PCR products appeared distinct from those having normal sequences. Figure 2a shows samples with intact sequence eluted as single peaks, whereas multiple peaks consisting of the homoduplex and the heteroduplex formations characterized heterozygous samples. In our experience, analysis of PCR fragments by dHPLC gives optimal resolution and reproducibility when the peak height of the eluted PCR product is greater than 3 mV. The identification rate of false-positive PCR products ranged from 10% to 20% when peaks were less than 3 mV, and therefore, these fragments were reanalyzed after reinjection of a larger sample volume.
The results of the dHPLC analysis were compared with sequencing ( Fig. 2b) and RFLP data, which were independently performed. Concerning the dHPLC results, we did not miss any alteration seen in cycle sequencing and gained a new alteration (T/C -13913 ) not previously identified by RFLP. In fact, in 2 healthy Sardinian controls with C/C -13910 genotype, the polymorphism T/C -13913 was also identified, which was clearly differentiated by dHPLC by means of the different shapes of the heteroduplex profiles ( Fig. 3a, b) .
In this study, we first optimized the conditions of the dHPLC-based analysis of the C/T -13910 polymorphism and then compared the results of dHPLC analysis with those obtained by sequencing and RFLP-based methods. By using dHPLC results, we obtained a sensitivity of 100% because we were able to predict all the alterations seen by DNA sequencing in all samples. No false-positive or false-negative signals were detected. Moreover, we also observed that the dHPLC tool was able to easily recognize new variations 12 not identified by the standard RFLP method. Thus, dHPLC allows us to distinguish between locus-specific variations within a fragment because the heteroduplex elution profiles have a unique characteristic form. In the case of known genetic variations, the nucleotide change can be predicted independently from the sequencing information because of the differences in heteroduplex elution times and profiles.
The traditional DNA sequencing-based tests are noninvasive and highly accurate but are still expensive and time-and laborconsuming (e.g., 1st purification of PCR products, sequencing reaction, and 2nd purification) and cannot be extensively used in routine clinical practice. The dHPLC assay is a new method to identify mutations and polymorphisms in crude PCR-amplified double-stranded DNA fragments. On the basis of our experience, the operational cost of the genotype-sequencing method for 100 samples was about US$12 and required about 4 days for processing versus US$1 and 24 h for the dHPLC method. Comparisons were based on reagent and labor cost specific to each assay and did not include the cost of equipment, repeat testing, or sample processing common to both assays (e.g., DNA preparation and laboratory overhead). Recently, different molecular approaches to detect the C/T -13910 polymorphism have been proposed by several authors 2,10,13-15 with different technical features ( Table 2) . Comparing all methods, the most favorable remains dHPLC. Therefore, this method allows clinical researchers to test several samples with higher accuracy, lower cost, and faster acquisition of results. The dHPLC assay could be employed in clinical practice alternatively to the direct and indirect tests [16] [17] [18] generally performed for diagnosis of lactose nonpersistence or in large-scale population studies.
Genotyping the LCT -13910 variant in 2 different populations
In Apulia and Sardinia controls and in CRC patients, the alleles at the C/T -13910 locus were in Hardy-Weinberg equilibrium with nonsignificant χ 2 values ( Table 3) . C/C, C/T, and T/T genotypes at locus -13910 were found in 82%, 17%, and 1% of healthy controls from Apulia and 88%, 11%, and 1% of healthy controls from Sardinia (Table 3) , respectively, without any statistically significant difference between the 2 control populations. CRC patients from Apulia show the same genotype distribution of healthy controls of the same geographical area without any significant difference: 80% had the C/C genotype, and the remaining 20% had the C/T one. Finally, no statistically significant difference in genotype frequency was observed in CRC patients when patients were sorted by tumor location, AJCC stage, and histological grading.
Our study clearly shows that lactase nonpersistence, defined by the C/C -13910 variant upstream of the LCT gene, is common in Apulian and Sardinian populations and is not associated with an increased risk of CRC, at least in the Italian population. These results are in agreement with previous studies in which the 19 Recently, resequencing of the LCT gene revealed 3 new SNPs (C/G -13907 , T/C -13913 , T/G -13915 ) in close proximity to C/T -13910 , and the most frequent of these (-13915G) is associated with lactose tolerance in 1 cohort of African populations. 12 Therefore, the availability of dHPLC makes high-throughput mutation screening of the LCT gene an efficient and feasible method for research and clinical diagnostic setting. Our study also shows no significant difference in LCT-C/T -13910 genotypes in CRC patients when compared to controls, implying that adult-type hypolactasia (or lactose malabsorption) and, possibly, dairy product consumption, are not the main determinants of CRC risk in the Italian population.
CONCLUSION
The dHPLC assay is a rapid and highly sensitive method for characterizing the C/T -13910 polymorphic site of the LCT gene involved in lactase persistence. The dHPLC tool is also suitable for screening large numbers of samples. The test may assist in differentiating patients with primary hypolactasia from those with secondary hypolactasia and may be employed in epidemiological studies, as suggested by Taylor and others. 9 In Italy, adult-type hypolactasia is very common and is not associated with an increased risk of CRC, as similarly found in British and Spanish populations.
